Regulation of Tumor Growth by Leukocyte-Specific Protein 1 in T Cells

Total Page:16

File Type:pdf, Size:1020Kb

Regulation of Tumor Growth by Leukocyte-Specific Protein 1 in T Cells Open access Original research J Immunother Cancer: first published as 10.1136/jitc-2020-001180 on 5 October 2020. Downloaded from Regulation of tumor growth by leukocyte-­specific­protein­1­in­T­cells Riri Kwon,1,2 Bong- Ki Hong,1 Kang- Gu Lee,1,2 Eunbyeol Choi,1,2 Laurent Sabbagh,3 1,4 1 1,4 Chul- Soo Cho, Naeun Lee, Wan- Uk Kim To cite: Kwon R, Hong B- K, ABSTRACT determines tumor progression and the effi- Lee K- G, et al. Regulation of Background Clinical efficacy of T cell- based cancer cacy of antitumor immunotherapy, including tumor growth by leukocyte- immunotherapy is limited by the lack of T cell infiltration specific protein 1 inT cells. antibody (Ab)- based immunotherapy against in the tumor mass, especially in solid tumors. Our group 1–3 Journal for ImmunoTherapy programmed cell death protein 1 (PD-1). demonstrated previously that leukocyte- specific protein of Cancer 2020;8:e001180. Several studies have suggested that a high doi:10.1136/jitc-2020-001180 1 (LSP1), an intracellular signal regulator, negatively regulates T cell infiltration in inflamed tissues. density of T cells positively correlates with Methods To determine the immuno- regulatory effects favorable prognosis and survival in patients ► Additional material is published online only. To view, of LSP1 in T cells on tumor progression, we investigated with various cancers, including colorectal, please visit the journal online the growth of B16 melanoma in Lsp1 knockout (KO) mice non-small cell lung, hepatocellular, pancreatic (http:// dx. doi. org/ 10. 1136/ jitc- and T cell- specific Lsp1 transgenic (Tg) mice. The immune and gastric cancers and melanoma.1 2 There- 2020- 001180). cell subpopulation infiltrated into the tumor mass as well fore, adoptive cell transfer using antigen- as the expression of interferon-gamma (IFN-γ) and tumor activated T cells, particularly chimeric antigen Accepted 07 September 2020 necrosis factor- alpha (TNF-α) in T cells was assessed by flow cytometry and/or immunohistochemistry. Chemotactic receptor (CAR)- T cells, has emerged as one migration was assayed with Lsp1 KO and Lsp1 Tg T of the promising strategies to improve the 4 cells. Adoptive transfer of Lsp1 KO or Lsp1 Tg T cells was efficacy of anticancer therapy. For example, performed in B16 melanoma-challenged Rag1 KO mice. CD19- targeted CAR-T cell therapy has shown Results Lsp1 KO mice showed decreased growth of remarkably high rates of remission in patients B16 melanoma and increased infiltration of T cells in the with hematological malignancies, including tumor mass, which were completely reversed in T cell- + relapsed or refractory B- cell acute lympho- specificLsp1 Tg mice. Lsp1 KO CD8 T cells also exhibited 4 5 elevated migratory capacity in response to CXCL9 and blastic leukemia and lymphoma. CXCL10, whereas Lsp1 Tg CD8+ T cells did the opposite. Despite its success in hematological malig- LSP1 expression was increased in tumor- infiltrating T nancies, CAR- T cell therapy is not always effi- http://jitc.bmj.com/ cells and could be induced by T cell receptor activation. cacious and has shown rather disappointing © Author(s) (or their Intriguingly, gene expression profiling ofLsp1 KO T cells employer(s)) 2020. Re- use results in some patients with solid tumors. One permitted under CC BY. suggested enhanced cytotoxicity. Indeed, expression of + of the major hurdles of T cell- based cancer Published by BMJ. IFN-γ and TNF-α was increased in tumor- infiltrating CD4 + immunotherapies is insufficient trafficking 1 and CD8 T cells of Lsp1 KO mice, while it was markedly Center for Integrative of T cells into tumor masses.4 6 Despite the Rheumatoid Transcriptomics reduced in those of Lsp1 Tg mice. Adoptive transfer of infusion of large amounts of T cells after ex on September 25, 2021 by guest. Protected copyright. and Dynamics, The Catholic Lsp1 KO T cells to Rag1 KO mice was more effective in University of Korea, Seoul, suppressing melanoma growth than transfer of Lsp1 Tg vivo expansion, only a small portion of trans- Republic of Korea T cells. Of note, when treated with antiprogrammed cell ferred T cells reaches inside the tumor tissues 2 Department of Biomedicine & death protein 1 (PD-1) antibody, inhibition of melanoma in clinical and preclinical studies.7 Although Health Sciences, The Catholic growth was more pronounced in Lsp1 KO mice than in University of Korea, Seoul, it remains unclear why trafficking, infiltration Lsp1- sufficient mice, suggesting that Lsp1 depletion and penetration of T cells are insufficient, it Republic of Korea additively increases the antitumor effects of anti- PD-1 3Department of Microbiology, antibody. may be primarily because solid tumors shape Infectiology, and Immunology, more fibrotic and less invasive environments University of Montreal, Montreal, Conclusions LSP1 in T cells regulates the growth of B16 melanoma in mice, possibly by affecting migration and through the activation of tumor- associated Quebec, Canada 8 4Division of Rheumatology, infiltration of T cells into the tumor and by modulating fibroblasts, ultimately constructing immu- + Department of Internal Medicine, production of antitumor effector cytokines by CD8 T cells. nosuppressive tumor microenvironments The Catholic University of Korea, These findings provide evidence that LSP1 can be a target (TME). Thus, to maximize the efficacy of T Seoul, Republic of Korea to improve the efficacy of T cell-based immunotherapy. cell- based immunotherapy for solid tumors, Correspondence to it is essential to develop innovative ways for Professor Wan- Uk Kim; BACKGROUND the successful delivery of immunocompetent wan725@ catholic. ac. kr Immune contexture, which consists of the T cells inside the tumor mass by destroying Dr Naeun Lee; density, composition and functional status or detouring fibrotic and immunosuppressive nelee2015@ catholic. ac. kr of tumor- infiltrating leukocytes (TILs), TME.8 9 Kwon R, et al. J Immunother Cancer 2020;8:e001180. doi:10.1136/jitc-2020-001180 1 Open access J Immunother Cancer: first published as 10.1136/jitc-2020-001180 on 5 October 2020. Downloaded from Leukocyte- specific protein 1 (LSP1) is an intracellular then PCR analysis of the Lsp1 transgene was performed F- actin- binding protein that is mainly expressed in hema- using the following primer sequences: forward, 5’-GGAC topoietic cells, such as T and B lymphocytes, neutrophils TCCA CCAG TCTC ACTTCAG-3’ and reverse, 5’- CAGT and macrophages.10 Previous studies have reported a TCAG AGGA CTTC AGGCTGAT-3’. G protein signaling negative regulatory role of LSP1 in leukocyte recruitment 7 gene (Rgs7) was used as an internal control with the to inflamed sites.10–12 After peritoneal injection of thiogly- primers 5’- CAAC CACT TACA AGAG ACCCGTA-3’ and 5’- colate or intra- articular injection of zymosan, infiltration GAGC CCTT AGAA ATAA CGTTCACC-3’. of macrophages and neutrophils was found to be higher For the adoptive transfer experiments using T cells, in inflamed tissues of Lsp1 knockout (KO) mice than in Rag1 KO mice were obtained from Jackson Labora- those of wild-type (WT) mice.11 12 Recently, our group also tory (Bar Harbor, Maine, USA). All strains were in the demonstrated that loss of Lsp1 promotes T cell migration C57BL/6 background, and age-matched and sex- matched into arthritic synovia and draining lymph nodes in mice WT C57BL/6 mice were used as a control. with T cell- dependent chronic inflammation.13 Interest- ingly, several reports have suggested a possible link of Induction of B16 melanoma in mice LSP1 to the pathogenesis of various cancers, including The B16BL6 melanoma cell line (hereafter termed ‘B16 breast cancer,14–16 bladder cancer,17 dermatofibroma18 melanoma’) was purchased from the Korean Cell Line and hepatocellular carcinoma19 20 beyond its role in the Bank (Seoul, Korea). The Lewis lung carcinoma (LLC) migration of immune cells. For example, genetic variation cell line was obtained from the American Type Culture in LSP1 has been implicated in susceptibility, prognostic Collection (Manassas, Virginia, USA). The MC38 colon outcomes and as a diagnostic marker in diverse types adenocarcinoma cell line was kindly provided by Dr of cancers.14–19 21 Moreover, a recent study showed that Tai- Gyu Kim (The Catholic University of Korea, Seoul, high LSP1 levels in glioblastoma serve as an independent Korea). All cell lines were cultured in Dulbecco’s Modi- predictive factor of unfavorable prognosis.22 However, it fied Eagle Medium (Welgene, Gyeongsan, Korea) supple- remains unclear whether LSP1 in T cells directly regu- mented with 10% heat-inactivated fetal bovine serum lates tumor growth and how it contributes to the patho- (FBS), 100 U/mL penicillin, 100 μg/mL streptomycin genesis of cancers. and 0.25 μg/mL Fungizone (Gibco; Thermo Fisher In this study, we postulated that Lsp1 deficiency Scientific, Waltham, Massachusetts, USA). All cell lines promotes the antitumor activity of T cells by inducing used in this study were negative for Mycoplasma, when cell migration and invasion into the tumor mass. We tested using an e- Myco Mycoplasma PCR Detection Kit demonstrated that Lsp1 deficiency in T cells suppresses (iNtRON Biotec, Seongnam, Korea). After being resus- the growth of B16 melanoma in mice, which seems to be pended in phosphate buffered saline (PBS), 5×105 B16 mediated by increased infiltration of CD8+ T cells into melanoma cells, 1×105 MC38 cells or 2.5×105 LLC cells tumor sites and by enhanced production of interferon- were injected subcutaneously into the right flank of mice gamma (IFN-γ) and tumor necrosis factor- alpha (TNF-α), aged 8–12 weeks. Tumor volumes were measured every http://jitc.bmj.com/ antitumor effector cytokines, by T cells. In contrast, Lsp1- 2–3 days with a caliper and calculated according to the overexpressing T cells show the opposite results. Notably, following formula: V(mm3)=D×d2×0.52, where D (mm) Lsp1 KO further potentiates the suppressive effect of anti- and d (mm) are the largest and smallest perpendicular PD-1 Ab on melanoma growth.
Recommended publications
  • Aberrant Methylation Underlies Insulin Gene Expression in Human Insulinoma
    ARTICLE https://doi.org/10.1038/s41467-020-18839-1 OPEN Aberrant methylation underlies insulin gene expression in human insulinoma Esra Karakose1,6, Huan Wang 2,6, William Inabnet1, Rajesh V. Thakker 3, Steven Libutti4, Gustavo Fernandez-Ranvier 1, Hyunsuk Suh1, Mark Stevenson 3, Yayoi Kinoshita1, Michael Donovan1, Yevgeniy Antipin1,2, Yan Li5, Xiaoxiao Liu 5, Fulai Jin 5, Peng Wang 1, Andrew Uzilov 1,2, ✉ Carmen Argmann 1, Eric E. Schadt 1,2, Andrew F. Stewart 1,7 , Donald K. Scott 1,7 & Luca Lambertini 1,6 1234567890():,; Human insulinomas are rare, benign, slowly proliferating, insulin-producing beta cell tumors that provide a molecular “recipe” or “roadmap” for pathways that control human beta cell regeneration. An earlier study revealed abnormal methylation in the imprinted p15.5-p15.4 region of chromosome 11, known to be abnormally methylated in another disorder of expanded beta cell mass and function: the focal variant of congenital hyperinsulinism. Here, we compare deep DNA methylome sequencing on 19 human insulinomas, and five sets of normal beta cells. We find a remarkably consistent, abnormal methylation pattern in insu- linomas. The findings suggest that abnormal insulin (INS) promoter methylation and altered transcription factor expression create alternative drivers of INS expression, replacing cano- nical PDX1-driven beta cell specification with a pathological, looping, distal enhancer-based form of transcriptional regulation. Finally, NFaT transcription factors, rather than the cano- nical PDX1 enhancer complex, are predicted to drive INS transactivation. 1 From the Diabetes Obesity and Metabolism Institute, The Department of Surgery, The Department of Pathology, The Department of Genetics and Genomics Sciences and The Institute for Genomics and Multiscale Biology, The Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
    [Show full text]
  • Analysis of Gene Expression Data for Gene Ontology
    ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION A Thesis Presented to The Graduate Faculty of The University of Akron In Partial Fulfillment of the Requirements for the Degree Master of Science Robert Daniel Macholan May 2011 ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION Robert Daniel Macholan Thesis Approved: Accepted: _______________________________ _______________________________ Advisor Department Chair Dr. Zhong-Hui Duan Dr. Chien-Chung Chan _______________________________ _______________________________ Committee Member Dean of the College Dr. Chien-Chung Chan Dr. Chand K. Midha _______________________________ _______________________________ Committee Member Dean of the Graduate School Dr. Yingcai Xiao Dr. George R. Newkome _______________________________ Date ii ABSTRACT A tremendous increase in genomic data has encouraged biologists to turn to bioinformatics in order to assist in its interpretation and processing. One of the present challenges that need to be overcome in order to understand this data more completely is the development of a reliable method to accurately predict the function of a protein from its genomic information. This study focuses on developing an effective algorithm for protein function prediction. The algorithm is based on proteins that have similar expression patterns. The similarity of the expression data is determined using a novel measure, the slope matrix. The slope matrix introduces a normalized method for the comparison of expression levels throughout a proteome. The algorithm is tested using real microarray gene expression data. Their functions are characterized using gene ontology annotations. The results of the case study indicate the protein function prediction algorithm developed is comparable to the prediction algorithms that are based on the annotations of homologous proteins.
    [Show full text]
  • Original Article Correlation Between LSP1 Polymorphisms and the Susceptibility to Breast Cancer
    Int J Clin Exp Pathol 2015;8(5):5798-5802 www.ijcep.com /ISSN:1936-2625/IJCEP0005835 Original Article Correlation between LSP1 polymorphisms and the susceptibility to breast cancer Hai Chen, Xiaodong Qi, Ping Qiu, Jiali Zhao Department of Galactophore, The General Hospital of Beijing Military Command, Beijing, China Received January 12, 2015; Accepted March 16, 2015; Epub May 1, 2015; Published May 15, 2015 Abstract: Objective: The present study aimed at assessing the relationship between Leukocyte-specific protein 1 gene (LSP1) polymorphisms (rs569550 and rs592373) and the pathogenesis of breast cancer (BC). Methods: 70 BC patients and 72 healthy subjects were enrolled in the study. Rs569550 and rs592373 polymorphisms were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Odds ratio (OR) with 95% confidence interval (CI) were calculated by the chi-squared test to assess the relationship between LSP1 polymorphisms and BC risk. Linkage disequilibrium (LD) and haplotypes were also analyzed by HaploView software. Results: Genotype distribution of the control was in accordance with Hardy-Weinberg equilibrium (HWE). The homo- zygous genotype TT and T allele of rs569550 could significantly increase the risk of BC (TT vs. GG: OR=3.17, 95% CI=1.23-8.91; T vs. G: OR=1.63, 95% CI=1.01-2.64). For rs592373, mutation homozygous genotype CC and C allele were significantly associated with BC susceptibility (CC vs. TT: OR=4.45, 95% CI=1.38-14.8; C vs. T: OR=1.70, 95% CI=1.03-2.81). LD and haplotypes analysis of rs569550 and rs592373 polymorphisms showed that T-C haplotype was a risk factor for BC (T-C vs.
    [Show full text]
  • Meta-Analysis of Nasopharyngeal Carcinoma
    BMC Genomics BioMed Central Research article Open Access Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformation Xia Chen†1,2, Shuang Liang†1, WenLing Zheng1,3, ZhiJun Liao1, Tao Shang1 and WenLi Ma*1 Address: 1Institute of Genetic Engineering, Southern Medical University, Guangzhou, PR China, 2Xiangya Pingkuang associated hospital, Pingxiang, Jiangxi, PR China and 3Southern Genomics Research Center, Guangzhou, Guangdong, PR China Email: Xia Chen - [email protected]; Shuang Liang - [email protected]; WenLing Zheng - [email protected]; ZhiJun Liao - [email protected]; Tao Shang - [email protected]; WenLi Ma* - [email protected] * Corresponding author †Equal contributors Published: 7 July 2008 Received: 16 February 2008 Accepted: 7 July 2008 BMC Genomics 2008, 9:322 doi:10.1186/1471-2164-9-322 This article is available from: http://www.biomedcentral.com/1471-2164/9/322 © 2008 Chen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Epstein-Barr virus (EBV) presumably plays an important role in the pathogenesis of nasopharyngeal carcinoma (NPC), but the molecular mechanism of EBV-dependent neoplastic transformation is not well understood. The combination of bioinformatics with evidences from biological experiments paved a new way to gain more insights into the molecular mechanism of cancer. Results: We profiled gene expression using a meta-analysis approach. Two sets of meta-genes were obtained. Meta-A genes were identified by finding those commonly activated/deactivated upon EBV infection/reactivation.
    [Show full text]
  • LSP1-Myosin1e Bi-Molecular Complex Regulates Focal Adhesion Dynamics
    bioRxiv preprint doi: https://doi.org/10.1101/2020.02.26.963991; this version posted February 27, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. LSP1-myosin1e bi-molecular complex regulates focal adhesion dynamics and cell migration Katja Schäringer1*, Sebastian Maxeiner1*, Carmen Schalla1, Stephan Rütten2, Martin Zenke1 and Antonio Sechi1 1Institute of Biomedical Engineering, Dept. of Cell Biology, RWTH Aachen University, Pauwelsstrasse, 30, D-52074 Aachen, Germany 2Electron Microscopy Facility, Institute of Pathology, RWTH Aachen University, Pauwelsstrasse, 30, D-52074 Aachen, Germany *equal contribution Corresponding author: Email: [email protected] Telephone: +49 241 8085248 Running head: LSP1-myosin1e complex regulates cell migration. Keywords: Actin cytoskeleton remodelling, focal adhesions, cell motility, macrophages. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.02.26.963991; this version posted February 27, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Several cytoskeleton-associated proteins and signalling pathways work in concert to regulate actin cytoskeleton remodelling, cell adhesion and migration. We have recently demonstrated that the bi-molecular complex between the leukocyte-specific protein 1 (LSP1) and myosin1e controls actin cytoskeleton remodelling during phagocytosis. In this study, we show that LSP1 down regulation severely impairs cell migration, lamellipodia formation and focal adhesion dynamics in macrophages. Inhibition of the interaction between LSP1 and myosin1e also impairs these processes resulting in poorly motile cells, which are characterised by few and small lamellipodia.
    [Show full text]
  • Anti-LSP1 Antibody (ARG55377)
    Product datasheet [email protected] ARG55377 Package: 50 μl anti-LSP1 antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes LSP1 Tested Reactivity Hu Tested Application WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name LSP1 Antigen Species Human Immunogen Synthetic peptide corresponding to aa. 121-149 of Human LSP1. Conjugation Un-conjugated Alternate Names Lymphocyte-specific protein 1; pp52; 52 kDa phosphoprotein; 47 kDa actin-binding protein; WP34; Lymphocyte-specific antigen WP34 Application Instructions Application table Application Dilution WB 1:1000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control Daudi Calculated Mw 37 kDa Properties Form Liquid Purification Affinity purification with immunogen. Buffer PBS (without Mg2+ and Ca2+, pH 7.4), 150mM NaCl, 0.02% Sodium azide and 50% Glycerol Preservative 0.02% Sodium azide Stabilizer 50% Glycerol Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. www.arigobio.com 1/2 Bioinformation Database links GeneID: 4046 Human Swiss-port # P33241 Human Gene Symbol LSP1 Gene Full Name lymphocyte-specific protein 1 Background This gene encodes an intracellular F-actin binding protein. The protein is expressed in lymphocytes, neutrophils, macrophages, and endothelium and may regulate neutrophil motility, adhesion to fibrinogen matrix proteins, and transendothelial migration.
    [Show full text]
  • Expression of Mouse LSP1/S37 Isoforms S37 Is Expressed in Embryonic Mesenchymal Cells
    Journal of Cell Science 107, 3591-3600 (1994) 3591 Printed in Great Britain © The Company of Biologists Limited 1994 Expression of mouse LSP1/S37 isoforms S37 is expressed in embryonic mesenchymal cells V. L. Misener1, C.-c. Hui2, I. A. Malapitan1, M.-E. Ittel1, A. L. Joyner2,3 and J. Jongstra1,* 1The Arthritis Centre-Research Unit, The Toronto Hospital Research Institute and Department of Immunology, University of Toronto, Toronto, Ontario, Canada 2Division of Molecular and Developmental Biology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada 3Department of Molecular and Medical Genetics, University of Toronto, Toronto, Ontario, Canada *Author for correspondence at: Toronto Western Hospital, Room 13-419, 399 Bathurst Street, Toronto, Ontario, M5T 2S8 Canada SUMMARY Mouse LSP1 is a 330 amino acid intracellular F-actin 18 bp encoding the 6 amino acids HLIRHQ of the acidic binding protein expressed in lymphocytes and domain. Therefore, the Lsp1 gene encodes four protein macrophages but not in non-hematopoietic tissues. A 328 isoforms: full-length LSP1 and S37 proteins, designated amino acid LSP1-related protein, designated S37, is LSP1-I and S37-I and the same proteins without the expressed in murine bone marrow stromal cells, in fibro- HLIRHQ sequence, designated LSP1-II and S37-II. By in blasts, and in a myocyte cell line. The two proteins differ situ hybridization analysis we show that the S37 isoforms only at their N termini, the first 23 amino acid residues of are expressed in mesenchymal tissue, but not in adjacent LSP1 being replaced by 21 different residues in S37. The epithelial tissue, of several developing organs during mouse presence of different amino termini suggests that the LSP1 embryogenesis.
    [Show full text]
  • Integrative Differential Expression and Gene Set Enrichment Analysis Using Summary Statistics for Scrna-Seq Studies
    ARTICLE https://doi.org/10.1038/s41467-020-15298-6 OPEN Integrative differential expression and gene set enrichment analysis using summary statistics for scRNA-seq studies ✉ Ying Ma 1,7, Shiquan Sun 1,7, Xuequn Shang2, Evan T. Keller 3, Mengjie Chen 4,5 & Xiang Zhou 1,6 Differential expression (DE) analysis and gene set enrichment (GSE) analysis are commonly applied in single cell RNA sequencing (scRNA-seq) studies. Here, we develop an integrative 1234567890():,; and scalable computational method, iDEA, to perform joint DE and GSE analysis through a hierarchical Bayesian framework. By integrating DE and GSE analyses, iDEA can improve the power and consistency of DE analysis and the accuracy of GSE analysis. Importantly, iDEA uses only DE summary statistics as input, enabling effective data modeling through com- plementing and pairing with various existing DE methods. We illustrate the benefits of iDEA with extensive simulations. We also apply iDEA to analyze three scRNA-seq data sets, where iDEA achieves up to five-fold power gain over existing GSE methods and up to 64% power gain over existing DE methods. The power gain brought by iDEA allows us to identify many pathways that would not be identified by existing approaches in these data. 1 Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA. 2 School of Computer Science, Northwestern Polytechnical University, Xi’an, Shaanxi 710072, P.R. China. 3 Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA. 4 Department of Human Genetics, University of Chicago, Chicago, IL 60637, USA. 5 Section of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
    [Show full text]
  • Transcriptome-Wide Profiling of Cerebral Cavernous Malformations
    www.nature.com/scientificreports OPEN Transcriptome-wide Profling of Cerebral Cavernous Malformations Patients Reveal Important Long noncoding RNA molecular signatures Santhilal Subhash 2,8, Norman Kalmbach3, Florian Wegner4, Susanne Petri4, Torsten Glomb5, Oliver Dittrich-Breiholz5, Caiquan Huang1, Kiran Kumar Bali6, Wolfram S. Kunz7, Amir Samii1, Helmut Bertalanfy1, Chandrasekhar Kanduri2* & Souvik Kar1,8* Cerebral cavernous malformations (CCMs) are low-fow vascular malformations in the brain associated with recurrent hemorrhage and seizures. The current treatment of CCMs relies solely on surgical intervention. Henceforth, alternative non-invasive therapies are urgently needed to help prevent subsequent hemorrhagic episodes. Long non-coding RNAs (lncRNAs) belong to the class of non-coding RNAs and are known to regulate gene transcription and involved in chromatin remodeling via various mechanism. Despite accumulating evidence demonstrating the role of lncRNAs in cerebrovascular disorders, their identifcation in CCMs pathology remains unknown. The objective of the current study was to identify lncRNAs associated with CCMs pathogenesis using patient cohorts having 10 CCM patients and 4 controls from brain. Executing next generation sequencing, we performed whole transcriptome sequencing (RNA-seq) analysis and identifed 1,967 lncRNAs and 4,928 protein coding genes (PCGs) to be diferentially expressed in CCMs patients. Among these, we selected top 6 diferentially expressed lncRNAs each having signifcant correlative expression with more than 100 diferentially expressed PCGs. The diferential expression status of the top lncRNAs, SMIM25 and LBX2-AS1 in CCMs was further confrmed by qRT-PCR analysis. Additionally, gene set enrichment analysis of correlated PCGs revealed critical pathways related to vascular signaling and important biological processes relevant to CCMs pathophysiology.
    [Show full text]
  • Impact of a Diet and Activity Health Promotion Intervention on Regional
    Hibler et al. Clinical Epigenetics (2019) 11:133 https://doi.org/10.1186/s13148-019-0707-0 RESEARCH Open Access Impact of a diet and activity health promotion intervention on regional patterns of DNA methylation Elizabeth Hibler1* , Lei Huang2, Jorge Andrade2,3 and Bonnie Spring1 Abstract Background: Studies demonstrate the impact of diet and physical activity on epigenetic biomarkers, specifically DNA methylation. However, no intervention studies have examined the combined impact of dietary and activity changes on the blood epigenome. The objective of this study was to examine the impact of the Make Better Choices 2 (MBC2) healthy diet and activity intervention on patterns of epigenome-wide DNA methylation. The MBC2 study was a 9-month randomized controlled trial among adults aged 18–65 with non-optimal levels of health behaviors. The study compared three 12-week interventions to (1) simultaneously increase exercise and fruit/ vegetable intake, while decreasing sedentary leisure screen time; (2) sequentially increase fruit/vegetable intake and decrease leisure screen time first, then increase exercise; (3) increase sleep and decrease stress (control). We collected blood samples at baseline, 3 and 9 months, and measured DNA methylation using the Illumina EPIC (850 k) BeadChip. We examined region-based differential methylation patterns using linear regression models with the false discovery rate of 0.05. We also conducted pathway analysis using gene ontology (GO), KEGG, and IPA canonical pathway databases. Results: We found no differences between the MBC2 population (n = 340) and the subsample with DNA methylation measured (n = 68) on baseline characteristics or the impact of the intervention on behavior change.
    [Show full text]
  • A Systems Genomics Approach to Uncover Patient-Specific Pathogenic Pathways and Proteins in a Complex Disease
    bioRxiv preprint doi: https://doi.org/10.1101/692269; this version posted July 4, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in a complex disease 1,2,3,4,§ 5,§ 1,4,6,§ 4,7 Johanne Brooks ,​ Dezso Modos ,​ Padhmanand Sudhakar ,​ David Fazekas ,​ Azedine ​ ​ ​ ​ 5 8 4 1,4 6,9 Zoufir ,​ Orsolya Kapuy ,​ Mate Szalay-Beko ,​ Matthew Madgwick ,​ Bram Verstockt ,​ Lindsay ​ ​ ​ ​ ​ 1,2 1,2,3 3 10 6,9 Hall Alastair​ Watson ,​ Mark Tremelling ,​ Miles Parkes ,​ Severine Vermeire ,​ Andreas ​ ​ ​ ​ ​ 5 1,2,* 1,4,* Bender ,​ Simon R. Carding ,​ Tamas Korcsmaros ​ ​ ​ 1 Gut Health and Microbes Programme, The Quadram Institute Bioscience, Norwich Research Park, Norwich, UK 2 ​ Norwich Medical School, University of East Anglia, Norwich, UK 3 ​ Department of Gastroenterology, Norfolk and Norwich University Hospitals, Norwich, UK 4 ​ Earlham Institute, Norwich Research Park, Norwich, UK 5 Centre​ for Molecular Science Informatics, Department of Chemistry, University of Cambridge, Cambridge, UK 6 ​ KU Leuven, Department of Chronic diseases, Metabolism and Ageing, Leuven, Belgium 7 ​ Department of Genetics, Eötvös Loránd University, Budapest, Hungary 8 Department​ of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary 9 University​ Hospitals Leuven, Department of Gastroenterology and Hepatology, KU Leuven, Leuven, Belgium 10 Inflammatory​ Bowel Disease Research Group, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK. § ​ equal contribution * ​ joint corresponding authors bioRxiv preprint doi: https://doi.org/10.1101/692269; this version posted July 4, 2019.
    [Show full text]
  • LSP1 (NM 001242932) Human Tagged ORF Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RG234186 LSP1 (NM_001242932) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: LSP1 (NM_001242932) Human Tagged ORF Clone Tag: TurboGFP Symbol: LSP1 Synonyms: pp52; WP34 Vector: pCMV6-AC-GFP (PS100010) E. coli Selection: Ampicillin (100 ug/mL) Cell Selection: Neomycin This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 4 LSP1 (NM_001242932) Human Tagged ORF Clone – RG234186 ORF Nucleotide >RG234186 representing NM_001242932 Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGGCTCCGATCTGGTCCCCACCTGGCAGGGTCTCCGGCTGTCACCTGAGTTCAGGACCAGCACCAGGAT CTGCAGTGGGCCCCTGGCTGGGCACACCTCATCCCAGCCTCCCCCTACCCCTGGCCCCCCATAAGCCTCC TCCTCCTGGGCTTCCAGGCTCTGCTGGTCAGACCTCCCTCCCTGCCCAACGGGAATGTGTTTTCCCAGGG GACGCTGCTGTCCACCAGGAGCTCTGTGGCCTGGGATTTGAGGAGTGCCTGGGGTCAATCCCCCAGGCTC ACCAGTGCTACTTAACAAATGGGCCCAAGAGAAGGAAGTGCAGCCCCCGGAGGAGGGGCAGAGCCCCTGC CTGGCTGTGCGGTGGCTCACCCCCTTGTCACCAGGGGCTCGGCCATGAGCATCCGTCCAGCGGGCCCAGC ACCAACTGCAGCCCCAGGCCCACTGCTCAGTGGAGCGTGGAGGACGAGGAGGAGGCCGTCCACGAGCAAT GCCAGCATGAGAGAGACAGGCAGCTTCAGGCCCAGGACGAGGAGGGAGGCGGCCATGTCCCCGAGCGGCC GAAGCAGGAGATGCTCCTCAGCCTGAAGCCCTCGGAGGCCCCTGAACTGGATGAGGACGAGGGCTTTGGC
    [Show full text]